Mar 28 Webinar: ComplianceAuthor™ for Clinical Labeling

Join us on Tuesday, March 28th as we introduce ComplianceAuthor™ for Clinical Labeling. The webinar, titled “Avoid High Risk, Non-Compliant Label Content”, will be presented by Tammy Feichtel and features a recent customer case study: a leading global healthcare company who leveraged ComplianceAuthor™ to yield profound value and benefits. The customer determined its manual processes […]

Read More

Mar 15-16: Visit us at Clinical Trial Supply, Barcelona

Glemser is a proud session sponsor of Arena’s upcoming Clinical Trial Supply (CTS) Europe conference. The conference will focus on incorporating new technologies to meet the demands of more complex, international clinical trial supply chains, and overcoming persistent clinical supply challenges. While in attendance, Glemser will introduce ComplianceAuthor™ for Clinical Labeling—our automated solution for end-to-end […]

Read More

Avoid High Risk, Non-Compliant Clinical Labeling Content

Pharmaceutical companies that conduct global clinical trials are required to produce booklet labels that comply with local regulatory requirements by country. A booklet label is a little booklet that is attached to the drug that is being distributed for a clinical trial. A single booklet label must be produced in multiple languages, representing the countries […]

Read More

Boehringer Ingelheim Implements Glemser Technology’s Solution for Increased Efficiency, Compliance, Longevity of Quality Management System

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies, family-owned and founded in 1885 in Germany. It employs more than 47,700 people on all continents and generated net sales of EUR 13,317 million in 2014. In evaluating its quality management processes, Boehringer Ingelheim sought a new, robust system to improve test specifications and […]

Read More